Malignant risk index in evaluation of menopausal ovarian cystic and cystic-solid tumors / 中华全科医师杂志

ABSTRACT

Clinical data of 349 patients with postmenopausal ovarian cystic and cystic solid tumors undergoing surgical treatment in Beijing Obstetrics and Gynecology Hospital affiliated to Capital Medical University from May 2013 to May 2017 were retrospectively analyzed.Postoperative pathology confirmed 100 cases of malignant tumor,228 cases of benign tumor,and 21 cases of borderline tumor.The malignant risk index (RMI) score was calculated based on the preoperative pelvic ultrasound and serum CA125 level,and the score＜200 was classified as benign tumors and ≥200 as malignant tumors.The postoperative pathological results were used as gold standard,the sensitivity,specificity,accurate rate of RMI in diagnosis of malignant tumors was 0.840(84/100),0.987 (225/228) and 94.2％ (309/328),respectively.The consistency of RMI with pathological diagnosis was high (Kappa=0.858,P＜0.05).The study suggests that RMI has a high degree of credibility for the evaluation of postmenopausal ovarian cystic and cystic solid tumors.